Biogen Inc. (NASDAQ:BIIB) Q3 2023 Results Earnings Conference Call November 8, 2023 8:00 AM ET

Company Participants

Chuck Triano - Head of Investor Relations

Christopher Viehbacher - President and Chief Executive Officer

Priya Singhal - Head of Development

Michael McDonnell - Chief Financial Officer

Conference Call Participants

Salveen Richter - Goldman Sachs

Geoff Meacham - Bank of America

Brian Abrahams - RBC Capital Markets

Robyn Karnauskas - Truist Securities

Umer Raffat - Evercore ISI

Michael Yee - Jefferies

Terence Flynn - Morgan Stanley

Paul Matteis - Stifel

Phil Nadeau - TD Cowen

Operator

Good morning. My name is Ally and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Biogen Third Quarter 2023 Earnings Call and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. Today's conference is being recorded. Thank you.

I would now like to turn the conference over to Mr. Chuck Triano, Head of Investor Relations. Mr. Triano, you may begin your conference.

Chuck Triano

Thank you, Ally. Good morning and welcome to Biogen's third quarter 2023 earnings call. Before we begin, I'll remind you that the earnings released and related financial tables including our GAAP financial measures and a reconciliation of the GAAP to non-GAAP financial measures that we will discuss today are located in the Investors section of biogen.com..

Our GAAP financials are provided in tables 1 and 2, and table 4 includes a reconciliation of our GAAP to non-GAAP financial results. We believe non-GAAP financial results better represent the ongoing economics of our business and reflect how we manage the business internally.

We have also posted slides on our website that follow the discussion related to this call.

I would like to point out that we will be making forward-looking statements, which are based on our expectations. These statements are subject to certain risks and uncertainties and our actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail.

So, on today's call, I'm joined by our President and Chief Executive Officer, Chris Viehbacher; Dr. Priya Singhal, Head of Development; and our CFO, Mike McDonnell. Chris, Priya, and Mike will each make some opening comments and then we'll move to the Q&A session. And to allow us to get through as many questions as possible, we kindly ask that you limit yourself to one question.